Vydeki Shanmuganathan Msc MRSB is currently a Principal Scientist (Microbiology) at Affinity Water. She graduated from University College London with a BSc (Hons) in Pharmacology. After graduating, she worked in a Food Microbiology Laboratory where her interest in microbiology was developed. Vydeki eventually moved into the water industry and then went on to gain her MSc in Microbiology at Birkbeck, University of London.
Linda Thomas PhD FIFST FRSB now works as a freelance scientist, having been Science Director at a probiotic company (Yakult UK Limited) for over a decade where she worked on clinical trials and directed healthcare professional educational activities in the UK and Ireland. Prior to this she was Principal Senior Scientist at Danisco, where she headed a research team developing novel natural antimicrobials for use in foods. This came after working as a post-doctoral researcher at Cardiff University, mainly investigating the influence of lactic acid bacteria and environmental factors on food safety. Her first job, having graduated in microbiology from University College London, was at the Central Public Health Laboratories at Colindale (now PHE), where she completed a PhD on the virulence of enteric pathogens and identified new serovars. She serves on several expert committees, is currently editor of the International Journal of Dairy Technology and is co-editing a book on Probiotic Dairy Products.
Emeritus Professor Michael W Fowler PhD CBiol FRSB FRSA FRSM, Department of Molecular Biology and Biotechnology, University of Sheffield. Mike trained as a biochemist (BSc, Kings College, London; PhD, Fitzwilliam College, Cambridge). He then spent two years as an ICI Pharmaceuticals Research Fellow at the University of Leicester, before moving to a Lectureship in Biochemistry in the University of Sheffield. In the early 1980s Mike's research group in the Sheffield Department of Biochemistry was used by the University as the basis of a new Wolfson Institute of Biotechnology, one of the first in the UK, and he was appointed its first Director and professor. Not long afterwards the Wolfson Institute itself was the basis for the first Sheffield company spin out, Plant Science Ltd, with 3i as the lead investor. This company later became the basis of Phytera Inc, a USA Massachusetts based biopharma company funded by Commonwealth Bioventures Inc, and centred on novel drug discovery and development from natural product sources. Over the years Mike has worked closely with a number of the major international pharmaceutical companies as a research collaborator, advisor or consultant, including Glaxo and Merck to name but two. He moved partially into industry in his later career and has worked as CSO, CEO and company Chairman. He has been, and still retains the position of, Non-exectuive Director for a number of small biopharma companies. Mike has also worked with WHO in Geneva, and for many years was Senior Advisor in Biopharmaceuticals to UNIDO Vienna. He was involved in the early development and clinical trial stages of one of the leading current anti-cancer agents, docetaxol.
All attendees on this course will receive a certificate of attendance.
This event has been approved by the Royal Society of Biology for purposes of CPD and can be counted as 24 CPD points. CPD is an important area of most career paths. It offers a mechanism by which you can document the work you do above and beyond your job role, aiding upwards progression. At the Society we promote the importance of CPD to all our members and provide a simple system for maintaining your progress throughout the year.
Our training is supporting of our professional registers competency framework where commitment to CPD and also competence in 5 key areas is required. Either for those who are currently registered and wanting to update their skills or for those who are looking to apply for registration. This course has been identified as supporting competency development for: registered scientist or technician. Competency area: Personal responsibility.
(NB: Our training is there to support your skills development and attending this course only is not sufficient to meet the registers' competency requirement, this should be supported by other evidence of your competence in this area).
We evaluate all of our training events, to ensure that a high quality of training is maintained.
The learning style of this course will be ‘hands on' and interactive, therefore capacity is limited to 16 places which will be allocated on a first-come-first-served basis.